SCHEMBL10370547

SCHEMBL10370547

NS(=O)(=O)c1cc2cc(OCC(O)CO)ccc2s1

nearest known ligand 0.58

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA2 P00918 19/20 0.58
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
P2RY12 Q9H244 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10369404 0.90 CA2 (0.69) CA2
SCHEMBL10369130 0.82 CA2 (0.63) CA2
SCHEMBL10370337 0.78 CA2 (0.70) CA2
SCHEMBL10368849 0.78 CA2 (0.64) CA2
SCHEMBL10369623 0.78 CA2 (0.81) CA2
SCHEMBL3483161 0.76 CA2 (0.63) CA2
Hydrochloric Acid SCHEMBL10371505 0.76 CA2 (0.63) CA2
SCHEMBL11000996 0.76 CA2 (0.70) CA2
SCHEMBL10372421 0.75 CA2 (0.70) CA2
SCHEMBL10368291 0.75 CA2 (0.60) CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0129478-B1 2-SULFAMOYLBENZO (B) THIOPHENE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ELEVATED INTRAOCULAR PRESSURE MERCK & CO. INC. (US) 1990-01-17 EP disclosed
US-4788192-A TOPICALLY APPLYING; FOR GLAUCOMA MERCK & CO., INC. (US) 1988-11-29 US disclosed
US-4668697-A Elevated intraocular pressure lowering benzo-[b]-thiophene-2-sulfonamide derivatives, compositions, and method of use therefor MERCK & CO., INC. (US) 1987-05-26 US disclosed
EP-0129478-A2 2-Sulfamoylbenzo (b) thiophene derivatives, their preparation and pharmaceutical composition for the treatment of elevated intraocular pressure MERCK & CO. INC. (US) 1984-12-27 EP disclosed